198 related articles for article (PubMed ID: 30699364)
1. Saporin-loaded CD44 and EGFR dual-targeted nanogels for potent inhibition of metastatic breast cancer in vivo.
Chen J; He H; Deng C; Yin L; Zhong Z
Int J Pharm; 2019 Apr; 560():57-64. PubMed ID: 30699364
[TBL] [Abstract][Full Text] [Related]
2. EGFR and CD44 Dual-Targeted Multifunctional Hyaluronic Acid Nanogels Boost Protein Delivery to Ovarian and Breast Cancers In Vitro and In Vivo.
Chen J; Ouyang J; Chen Q; Deng C; Meng F; Zhang J; Cheng R; Lan Q; Zhong Z
ACS Appl Mater Interfaces; 2017 Jul; 9(28):24140-24147. PubMed ID: 28675028
[TBL] [Abstract][Full Text] [Related]
3. Bioresponsive and fluorescent hyaluronic acid-iodixanol nanogels for targeted X-ray computed tomography imaging and chemotherapy of breast tumors.
Zhu Y; Wang X; Chen J; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z
J Control Release; 2016 Dec; 244(Pt B):229-239. PubMed ID: 27568289
[TBL] [Abstract][Full Text] [Related]
4. Redox-Sensitive and Intrinsically Fluorescent Photoclick Hyaluronic Acid Nanogels for Traceable and Targeted Delivery of Cytochrome c to Breast Tumor in Mice.
Li S; Zhang J; Deng C; Meng F; Yu L; Zhong Z
ACS Appl Mater Interfaces; 2016 Aug; 8(33):21155-62. PubMed ID: 27509045
[TBL] [Abstract][Full Text] [Related]
5. CD44 targeting biocompatible and biodegradable hyaluronic acid cross-linked zein nanogels for curcumin delivery to cancer cells: In vitro and in vivo evaluation.
Seok HY; Sanoj Rejinold N; Lekshmi KM; Cherukula K; Park IK; Kim YC
J Control Release; 2018 Jun; 280():20-30. PubMed ID: 29723613
[TBL] [Abstract][Full Text] [Related]
6. Tumor-targeted and nitric oxide-generated nanogels of keratin and hyaluronan for enhanced cancer therapy.
Sun Z; Yi Z; Cui X; Chen X; Su W; Ren X; Li X
Nanoscale; 2018 Jul; 10(25):12109-12122. PubMed ID: 29915821
[TBL] [Abstract][Full Text] [Related]
7. pH-Sensitive Coiled-Coil Peptide-Cross-Linked Hyaluronic Acid Nanogels: Synthesis and Targeted Intracellular Protein Delivery to CD44 Positive Cancer Cells.
Ding L; Jiang Y; Zhang J; Klok HA; Zhong Z
Biomacromolecules; 2018 Feb; 19(2):555-562. PubMed ID: 29284258
[TBL] [Abstract][Full Text] [Related]
8. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
[TBL] [Abstract][Full Text] [Related]
9. CD44-Targeted Multifunctional Nanomedicines Based on a Single-Component Hyaluronic Acid Conjugate with All-Natural Precursors: Construction and Treatment of Metastatic Breast Tumors
Fang H; Zhao X; Gu X; Sun H; Cheng R; Zhong Z; Deng C
Biomacromolecules; 2020 Jan; 21(1):104-113. PubMed ID: 31532629
[TBL] [Abstract][Full Text] [Related]
10. CD44-tropic polymeric nanocarrier for breast cancer targeted rapamycin chemotherapy.
Zhao Y; Zhang T; Duan S; Davies NM; Forrest ML
Nanomedicine; 2014 Aug; 10(6):1221-30. PubMed ID: 24637218
[TBL] [Abstract][Full Text] [Related]
11. Novel CD44-targeting and pH/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis.
Shi J; Ren Y; Ma J; Luo X; Li J; Wu Y; Gu H; Fu C; Cao Z; Zhang J
J Nanobiotechnology; 2021 Jun; 19(1):188. PubMed ID: 34162396
[TBL] [Abstract][Full Text] [Related]
12. NIR and UV-responsive degradable hyaluronic acid nanogels for CD44-targeted and remotely triggered intracellular doxorubicin delivery.
Hang C; Zou Y; Zhong Y; Zhong Z; Meng F
Colloids Surf B Biointerfaces; 2017 Oct; 158():547-555. PubMed ID: 28743090
[TBL] [Abstract][Full Text] [Related]
13. Targeted delivery of honokiol by zein/hyaluronic acid core-shell nanoparticles to suppress breast cancer growth and metastasis.
Zhang Q; Wang J; Liu D; Zhu W; Guan S; Fan L; Cai D
Carbohydr Polym; 2020 Jul; 240():116325. PubMed ID: 32475585
[TBL] [Abstract][Full Text] [Related]
14. LHRH Targeted Chonderosomes of Mitomycin C in Breast Cancer: An
Varshosaz J; Sarrami N; Aghaei M; Aliomrani M; Azizi R
Anticancer Agents Med Chem; 2019; 19(11):1405-1417. PubMed ID: 30987576
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.
Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R
Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390
[TBL] [Abstract][Full Text] [Related]
16. Small, Traceable, Endosome-Disrupting, and Bioresponsive Click Nanogels Fabricated via Microfluidics for CD44-Targeted Cytoplasmic Delivery of Therapeutic Proteins.
Huang K; He Y; Zhu Z; Guo J; Wang G; Deng C; Zhong Z
ACS Appl Mater Interfaces; 2019 Jun; 11(25):22171-22180. PubMed ID: 31190543
[TBL] [Abstract][Full Text] [Related]
17. Redox sensitive nano-capsules self-assembled from hyaluronic acid-hydroxychloroquine conjugates for CD44-targeted delivery of hydroxychloroquine to combat breast cancer metastasis in vitro and in vivo.
He Y; Xu Y; Huang Y; Quang H; Xia X; Zhao H; Xiao Y; Lu W; Yu J
Colloids Surf B Biointerfaces; 2022 Feb; 210():112249. PubMed ID: 34864404
[TBL] [Abstract][Full Text] [Related]
18. Treating metastatic triple negative breast cancer with CD44/neuropilin dual molecular targets of multifunctional nanoparticles.
Liang DS; Zhang WJ; Wang AT; Su HT; Zhong HJ; Qi XR
Biomaterials; 2017 Aug; 137():23-36. PubMed ID: 28528300
[TBL] [Abstract][Full Text] [Related]
19. Dual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancer.
Yang Z; Luo H; Cao Z; Chen Y; Gao J; Li Y; Jiang Q; Xu R; Liu J
Nanoscale; 2016 Jun; 8(22):11543-58. PubMed ID: 27203688
[TBL] [Abstract][Full Text] [Related]
20. Cell Permeable NBD Peptide-Modified Liposomes by Hyaluronic Acid Coating for the Synergistic Targeted Therapy of Metastatic Inflammatory Breast Cancer.
Sun Y; Li X; Zhang L; Liu X; Jiang B; Long Z; Jiang Y
Mol Pharm; 2019 Mar; 16(3):1140-1155. PubMed ID: 30668131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
